Skip to main content

Rapidly Progressive Weakness

  • Chapter
  • First Online:
Neurology
  • 1614 Accesses

Abstract

The first step in evaluating a patient with rapidly progressive weakness is to ensure respiratory stability, intubating the patient if necessary. Measurements of negative inspiratory force and forced vital capacity help to determine which patients are in urgent need of intubation or closer respiratory monitoring. Once respiratory stability is ensured, identifying the initial pattern of weakness is the next step in establishing the diagnosis. Nerve conduction studies, electromyography, and other laboratory tests can then be used to differentiate among the various causes of weakness. The most important causes of rapidly progressive weakness are Guillain-Barre syndrome (GBS) and myasthenic crisis. Less common causes of rapidly progressive weakness include botulism, poliomyelitis, and spinal cord infarction. Critical illness neuromyopathy is a common source of failure to wean from the ventilator seen in patients who have undergone prolonged treatment in the ICU.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hughes JM, Blumenthal JR, Merson MH, et al. Botulinum stool and serum testing - clinical features of types A and B food-borne botulism. Ann Intern Med. 1981;95:442–5.

    Article  CAS  PubMed  Google Scholar 

  2. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol. 2001;58:913–7.

    Article  CAS  PubMed  Google Scholar 

  3. Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987;21:32–40.

    Article  CAS  PubMed  Google Scholar 

  4. Hughes RAC, Raphael JC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2006;(1):CD002063.

    Google Scholar 

  5. Raphael JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2002;(2):CD001798.

    Google Scholar 

  6. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med. 1992;326:1123–9.

    Article  PubMed  Google Scholar 

  7. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high dose immunoglobulin in myasthenia gravis. Ann Neurol. 1997;41:789–96.

    Article  CAS  PubMed  Google Scholar 

  8. Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve. 2011;44:36–40.

    Article  PubMed  Google Scholar 

  9. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis. 2000;31:1018–24.

    Article  CAS  PubMed  Google Scholar 

  10. McCroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol. 1988;26:1052–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173–9.

    Article  PubMed  Google Scholar 

  12. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit. A prospective multicenter study. JAMA. 2002;288:2859–67.

    Article  PubMed  Google Scholar 

  13. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47:1223–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol. 1996;40:645–54.

    Article  CAS  PubMed  Google Scholar 

  15. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve. 1997;20:665–73.

    Article  CAS  PubMed  Google Scholar 

  16. Gooch JL. AAEM Case Report #29: prolonged paralysis after neuromuscular blockade. Muscle Nerve. 1995;18:937–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tarulli, A. (2021). Rapidly Progressive Weakness. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-55598-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-55598-6_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-55597-9

  • Online ISBN: 978-3-030-55598-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics